Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1090
-
Total shares
-
74.8M
-
Shares change
-
+3.52M
-
Total reported value, excl. options
-
$36.4B
-
Value change
-
+$1.68B
-
Put/Call ratio
-
1.61
-
Number of buys
-
477
-
Number of sells
-
-484
-
Price
-
$487.20
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2024
filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2024.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,090 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.8M shares
of 80.8M outstanding shares and own 92.54% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.7M shares), BlackRock Inc. (9.6M shares), STATE STREET CORP (3.63M shares), ALLIANCEBERNSTEIN L.P. (3.14M shares), Fundsmith LLP (2.66M shares), GEODE CAPITAL MANAGEMENT, LLC (2.22M shares), BAMCO INC /NY/ (2.04M shares), FRANKLIN RESOURCES INC (1.38M shares), Invesco Ltd. (1.32M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.27M shares).
This table shows the top 1090 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.